Literature DB >> 28603728

Aspirin monotherapy vs. dual antiplatelet therapy in diabetic patients following coronary artery bypass graft (CABG): where do we stand?

Salem Salem1, Sameh Askandar2, Rami N Khouzam1.   

Abstract

Entities:  

Year:  2017        PMID： 28603728      PMCID： PMC5451608          DOI： 10.21037/atm.2017.03.98

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  10 in total

1.  Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: revascularization in diabetic patients.

Authors:  Sidney C Smith; David Faxon; Wayne Cascio; Hartzell Schaff; Timothy Gardner; Alice Jacobs; Steven Nissen; Rick Stouffer
Journal:  Circulation       Date:  2002-05-07       Impact factor: 29.690

2.  Management of Antiplatelet Therapy After Coronary Artery Bypass Grafting in the Setting of Acute Coronary Syndrome.

Authors:  Mate Petricevic; Marko Boban; Martina Z Mihaljevic; Bojan Biocina
Journal:  Am J Cardiol       Date:  2015-07-10       Impact factor: 2.778

3.  Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.

Authors:  Sean van Diepen; Valentin Fuster; Subodh Verma; Taye H Hamza; F Sandra Siami; Shaun G Goodman; Michael E Farkouh
Journal:  J Am Coll Cardiol       Date:  2017-01-17       Impact factor: 24.094

Review 4.  Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting in the Setting of Acute Coronary Syndrome.

Authors:  Ritin Bomb; Carrie S Oliphant; Rami N Khouzam
Journal:  Am J Cardiol       Date:  2015-04-08       Impact factor: 2.778

5.  Causes of primary graft failure after in situ saphenous vein bypass grafting.

Authors:  M C Donaldson; J A Mannick; A D Whittemore
Journal:  J Vasc Surg       Date:  1992-01       Impact factor: 4.268

6.  Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery.

Authors:  Tyler J Gluckman; Rhondalyn C McLean; Steven P Schulman; Thomas S Kickler; Edward P Shapiro; John V Conte; Kathleen W McNicholas; Jodi B Segal; Jeffrey J Rade
Journal:  J Am Coll Cardiol       Date:  2011-03-01       Impact factor: 24.094

7.  The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery.

Authors:  L Campeau; M Enjalbert; J Lespérance; M G Bourassa; P Kwiterovich; S Wacholder; A Sniderman
Journal:  N Engl J Med       Date:  1984-11-22       Impact factor: 91.245

Review 8.  Mechanisms of plaque formation and rupture.

Authors:  Jacob Fog Bentzon; Fumiyuki Otsuka; Renu Virmani; Erling Falk
Journal:  Circ Res       Date:  2014-06-06       Impact factor: 17.367

9.  Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial.

Authors:  Alexander Kulik; Michel R Le May; Pierre Voisine; Jean-Claude Tardif; Robert Delarochelliere; Sarika Naidoo; George A Wells; Thierry G Mesana; Marc Ruel
Journal:  Circulation       Date:  2010-12-06       Impact factor: 29.690

10.  Strategies for multivessel revascularization in patients with diabetes.

Authors:  Michael E Farkouh; Michael Domanski; Lynn A Sleeper; Flora S Siami; George Dangas; Michael Mack; May Yang; David J Cohen; Yves Rosenberg; Scott D Solomon; Akshay S Desai; Bernard J Gersh; Elizabeth A Magnuson; Alexandra Lansky; Robin Boineau; Jesse Weinberger; Krishnan Ramanathan; J Eduardo Sousa; Jamie Rankin; Balram Bhargava; John Buse; Whady Hueb; Craig R Smith; Victoria Muratov; Sameer Bansilal; Spencer King; Michel Bertrand; Valentin Fuster
Journal:  N Engl J Med       Date:  2012-11-04       Impact factor: 91.245
  10 in total
  1 in total

1.  Potential benefits of large database analysis.

Authors:  Slav Yartsev
Journal:  Ann Transl Med       Date:  2017-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.